News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

ACS IMPACT – Expanding Prostate Cancer Clinical Trials in the Community
Apr 20, 2025, 19:06

ACS IMPACT – Expanding Prostate Cancer Clinical Trials in the Community

The ACS IMPACT grant supports local oncology practices and hospitals in expanding clinical trial enrollment among Black men with prostate cancer. This initiative addresses the most significant mortality disparity in oncology and aims to enhance racial diversity in prostate cancer trials through targeted infrastructure support and partnerships with the Prostate Cancer Clinical Trials Consortium (PCCTC) and Trial Library.

Eligibility

  • Must have direct patient interaction and the ability to participate in clinical trials
  • Sites affiliated with an NCI-designated comprehensive cancer center must clearly justify how they will engage community practices and improve diversity
  • Institutions must be able to implement clinical infrastructure and community engagement efforts

Grant Term and Budget

  • Up to 200,000 USD/year in direct costs
  • Up to 2 years of funding with a potential 1-year extension based on demonstrated progress
  • Funds may support clinical staff, recruitment activities, and infrastructure to engage prostate cancer patients

Important Dates

  • Informational Webinar: September 16, 2024, 12–1 PM ET
  • LOI Deadline: September 30, 2024
  • Application Deadline: January 15, 2025
  • Anticipated Start Date: April 1, 2025

(If a deadline falls on a weekend or holiday, submissions are accepted the next business day)

ACS IMPACT American Cancer Society Black men in oncology cancer Cancer Health Disparities clinical research diversity clinical trials OncoDaily Oncology PCCTC prostate cancer prostate cancer mortality Trial Library
Special Coverage
Insight
Jun 13, 2025, 17:03
Mark Lawler: Great work by Ethna McFerran leading LungSHOT Project on Lung Cancer Screening in Ireland
Blog
Jun 13, 2025, 17:02
Jennifer Douglas: Before I Made a Surgical Decision, I Paused
Science
Jun 13, 2025, 16:45
Benoit Rousseau and Luis Diaz Shared New Findings on MMR Deficient Cancers Published in Cancer Cell by Cell Press
Insight
Jun 13, 2025, 16:39
Eric K. Singhi and Jarushka Naidoo Highlighted Study On Pooled Analysis of Datopotamab Deruxtecan in patients with EGFR–mutated NSCLC
Opinion
Jun 13, 2025, 16:13
BioNTech Acquires CureVac in €1.25B Deal to Expand mRNA Oncology Pipeline
Oncolibrary
Jun 13, 2025, 15:43
New Paper Alert: NRG‑NSABP B‑51/RTOG 1304 Trial on Regional Nodal Irradiation Omission in ypN0 Breast Cancer After Neoadjuvant Chemotherapy
Science
Jun 13, 2025, 15:38
Natalia Baran: Pleased To Share My Latest Review On The Gut-Immune Axis In Primary Immune Thrombocytopenia
Science
Jun 13, 2025, 15:08
Jim Baranski: Can AI Diagnose Lung Cancer?
Science
Jun 13, 2025, 14:09
Marco Donia: CAR-T Cells for Gastro-Oesophageal Cancer - First Randomized Trial of CAR-T in Solid Tumors
Oncolibrary
Jun 13, 2025, 13:39
Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect
Blog
Jun 13, 2025, 13:38
Tsetsegsaikhan Batmunkh: It Was a Pleasure To Meet Assistant Secretary Lucienne Manton from Australia in Mongolia
Opinion
Jun 13, 2025, 11:22
Mieke Van Hemelrijck: Updates on Prostate Cancer Care After Cancer Research UK DCSU Session at UKOF25